Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
385,837,333
-
Total 13F shares
-
17,535,838
-
Share change
-
+1,545,536
-
Total reported value
-
$316,682,561
-
Put/Call ratio
-
105%
-
Price per share
-
$18.06
-
Number of holders
-
91
-
Value change
-
+$27,816,315
-
Number of buys
-
40
-
Number of sells
-
35
Institutional Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q2 2015
As of 30 Jun 2015,
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) was held by
91 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,535,838 shares.
The largest 10 holders included
HEARTLAND ADVISORS INC, Boston Partners, ACK Asset Management LLC, CARDINAL CAPITAL MANAGEMENT LLC /CT, Paradice Investment Management LLC, Park West Asset Management LLC, BLAIR WILLIAM & CO/IL, KENNEDY CAPITAL MANAGEMENT, INC., THOMSON HORSTMANN & BRYANT INC, and Cortina Asset Management, LLC.
This page lists
91
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.